Support Innovation in Lysosomal Disease Research
The Lysosomal Disease Summit provides a focused platform for collaboration among clinicians, researchers, industry leaders, and patient advocacy organisations working across the lysosomal disease field.
Hosted in collaboration with Fabry Australia, the Summit brings together stakeholders from across the Asia–Pacific region and the global rare disease community to advance diagnostics, therapeutic development, and patient-centred care.
Industry partners play a vital role in supporting scientific exchange and accelerating progress in lysosomal disease research and treatment.
Why Sponsor the Lysosomal Disease Summit
- Connect with a highly targeted audience of clinicians, researchers, and rare disease experts focused on lysosomal and inherited metabolic disorders.
- Engage with decision-makers and clinical leaders from across the Asia–Pacific region and the international rare disease community.
- Demonstrate commitment to advancing innovation in diagnosis, treatment, and long-term care for patients with lysosomal diseases.
- Support a mission-driven meeting that fosters collaboration between clinical research, patient advocacy, and industry partners.
How to Get Involved
Organisations interested in supporting the Lysosomal Disease Summit are invited to submit a sponsorship application or contact the Summit team to discuss partnership opportunities.
Thank you to the 2025 Summit Sponsors
